Source: https://www.nytimes.com/2018/09/29/health/memorial-sloan-kettering-cancer-biotech-ethics.html?partner=rss&emc=rss
September 29, 2018 at 07:15PM
With the cancer center’s corporate ties under scrutiny, the hospital told employees that no one should profit personally from representing MSK on outside boards.
No comments:
Post a Comment